#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glomerulonephritis membranoproliferative Brain injury Exudative retinopathy Ewing's sarcoma Obesity Transitional cell cancer of the renal pelvis and ureter Mucopolysaccharidosis I Selective polysaccharide antibody deficiency Chronic lymphocytic leukaemia recurrent Ichthyosis Acute graft versus host disease in intestine Oesophageal squamous cell carcinoma stage III Castleman's disease Bile acid synthesis disorder Hereditary motor and sensory neuropathy More trials…

    Learn about Rare Diseases

    MELAS syndrome Langerhans cell sarcoma Cholangitis sclerosing – Treatment Cystic fibrosis lung – Life with Disease Idiopathic inflammatory myopathy – Basic Information Ewing’s sarcoma recurrent Castleman’s disease – Diagnostics Antisynthetase syndrome – Basic Information Adrenocortical carcinoma – Diagnostics Hepatoblastoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    BROLUCIZUMAB Maralixibat Chloride Placebo Tozinameran Transcon Il-2Β/Γ Amb-05X Remibrutinib Dexchlorpheniramine Cefalexin Alizapride Disulfiram Interleukin-2 ZUNIBERGENE ROCPARVOVEC Acou085 Isoflurane Rifabutin Mogamulizumab Belimumab Omalizumab Regadenoson More therapies…

    Learn about Your Condition

    Torticollis Status epilepticus Dry mouth Breast cancer stage III Supranuclear palsy Large cell lung cancer stage 0 Cerebellar ataxia Stomatitis Crigler-Najjar syndrome Cardiac amyloidosis Embolic stroke Rhabdomyosarcoma Kaposi's sarcoma Choroidal neovascularisation Osteomyelitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Fluconazole and Cefalexin Monohydrate for Treating Laryngeal Leukoplakia in Adults

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Laryngeal leukoplakia
    Investigated Drugs:
    • Cefalexin Monohydrate
    • Fluconazole
    Finland

  • Study of Atezolizumab with BCG Treatment for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Previously Received BCG

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Atezolizumab
    Belgium France Spain

  • Study on the Tolerability and Acceptance of Oral Hydrocortisone for Children with Adrenal Hyperplasia or Adrenal Insufficiency

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hyperplasia adrenal
    • Primary adrenal insufficiency
    Investigated Drugs:
    • Hydrocortisone Ph. Eur.
    Spain

  • Study on the Safety and Tolerability of INP20 for Peanut Allergy in Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Food allergy
    Spain

  • A Study of High-Concentration Oxygen Treatment in Patients with Heart Failure, Pulmonary Hypertension, and Coronary Microvascular Dysfunction

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypoxia
    • Pulmonary hypertension
    • Cardiac failure
    Investigated Drugs:
    • Oxygen
    The Netherlands

  • Study on the Effects of Botulinum Toxin A for Improving Arm Function in Patients with Chronic Stroke

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Cerebrovascular accident
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    France
Previous Page
1 … 859 860 861 862 863 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!